- Home
- IPSC vs CATO Comparison
IPSC vs CATO Comparison
Compare IPSC & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- CATO
- Stock Information
- Founded
- IPSC 2019
- CATO 1946
- Country
- IPSC United States
- CATO United States
- Employees
- IPSC N/A
- CATO N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- CATO Clothing/Shoe/Accessory Stores
- Sector
- IPSC Health Care
- CATO Consumer Discretionary
- Exchange
- IPSC Nasdaq
- CATO Nasdaq
- Market Cap
- IPSC 49.6M
- CATO 59.2M
- IPO Year
- IPSC 2021
- CATO N/A
- Fundamental
- Price
- IPSC $0.60
- CATO $3.16
- Analyst Decision
- IPSC Strong Buy
- CATO
- Analyst Count
- IPSC 5
- CATO 0
- Target Price
- IPSC $3.33
- CATO N/A
- AVG Volume (30 Days)
- IPSC 1.0M
- CATO 33.0K
- Earning Date
- IPSC 08-07-2025
- CATO 08-21-2025
- Dividend Yield
- IPSC N/A
- CATO 5.44%
- EPS Growth
- IPSC N/A
- CATO N/A
- EPS
- IPSC N/A
- CATO N/A
- Revenue
- IPSC $114,898,000.00
- CATO $642,949,000.00
- Revenue This Year
- IPSC $1,064.82
- CATO N/A
- Revenue Next Year
- IPSC N/A
- CATO N/A
- P/E Ratio
- IPSC N/A
- CATO N/A
- Revenue Growth
- IPSC 8286.72
- CATO N/A
- 52 Week Low
- IPSC $0.34
- CATO $2.19
- 52 Week High
- IPSC $3.29
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- IPSC 55.47
- CATO 63.89
- Support Level
- IPSC $0.52
- CATO $2.84
- Resistance Level
- IPSC $0.57
- CATO $3.05
- Average True Range (ATR)
- IPSC 0.04
- CATO 0.16
- MACD
- IPSC 0.00
- CATO 0.02
- Stochastic Oscillator
- IPSC 66.10
- CATO 100.00
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.